ImmuCell Corporation (ICCC)

NASDAQ: ICCC · Real-Time Price · USD

10.75

+0.53 (5.19%)

Nov 13, 2026, 4:00 PM EST - Market closed

ImmuCell Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	33.21	27.64	26.49	17.47	18.57	19.24
Revenue Growth	19.59%	4.35%	51.63%	-5.90%	-3.51%	25.42%
Gross Profit	13.56	11.45	7.94	4.4	8.24	8.66
Operating Income	5.6	2.45	-1.64	-5.22	-1.71	0.26
Net Income	1.88	-1.04	-2.16	-5.77	-2.49	-0.08
Earnings Per Share	0.20	-0.12	-0.26	-0.75	-0.32	-0.01
EPS Growth	-23.86%	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Scours	27.45	26.31	17.29	18.41	18.93
Mastitis	0.2	0.18	0.18	0.15	0.14
Total	27.64	26.49	17.47	18.57	19.24

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	7.91	3.81	3.76	0.98	5.79	10.19
Total Debt	12.01	13.19	15.1	16.69	12.48	10.27
Net Cash (Debt)	-4.1	-9.39	-11.34	-15.71	-6.69	-0.09
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.45	-1.04	-1.39	-2.03	-0.86	-0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	7.83	2.48	0.36	-4.67	-1.54	0.95
Capital Expenditures	-2.43	-1.25	-0.47	-1.89	-3.98	-2.61
Free Cash Flow	5.4	1.22	-0.11	-6.57	-5.52	-1.65
Free Cash Flow Growth	655.13%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	40.83%	41.40%	29.97%	25.16%	44.37%	44.98%
Operating Margin	16.88%	8.86%	-6.19%	-29.88%	-9.21%	1.34%
Pretax Margin	5.79%	-3.72%	-8.10%	-33.02%	-13.39%	-0.36%
Profit Margin	5.66%	-3.76%	-8.14%	-33.05%	-13.43%	-0.41%
FCF Margin	16.27%	4.43%	-0.41%	-37.59%	-29.72%	-8.60%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
P/FCF Ratio	18.07	45.42	-	-	-	-
PS Ratio	2.94	2.01	1.73	2.26	2.55	3.22